• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载脂蛋白[a]的酶联免疫测定法

Enzyme-linked immunoassay for Lp[a].

作者信息

Fless G M, Snyder M L, Scanu A M

机构信息

Department of Medicine, Pritzker School of Medicine, University of Chicago, IL 60637.

出版信息

J Lipid Res. 1989 May;30(5):651-62.

PMID:2527286
Abstract

Based on our findings that rabbit antisera raised against human Lp[a] or apo[a] have the potential to cross-react with plasminogen, and in some cases have nearly equal affinities for plasminogen and Lp[a], we have developed an assay for plasma Lp[a] based on a "sandwich" ELISA that is insensitive to the presence of plasminogen. This was accomplished through the use of anti-apo[a] as a capture antibody and quantitation of the bound Lp[a], i.e., the apoB-100-apo[a] complex, with an anti-apoB antibody. Although apo[a] is heterogeneous in size, all Lp[a] particles tested, either in pure form or contained in whole plasma, gave parallel dose-response curves and were immunologically equivalent. However, when purified Lp[a] particles with different apo[a] isoforms were studied, those having larger isoforms were, on a weight basis, less reactive than those having a smaller size. Nearly equivalent reactivity was observed when protein concentration was expressed on a molar basis. The distribution of Lp[a] in a population of 84 subjects was skewed with one-third of the individuals having less than 1 mg/dl Lp[a] protein. All subjects tested had measurable concentrations of Lp[a] with a lower limit of detection of 0.030 mg/dl Lp[a] protein. The mean level was 3.2 mg/dl with a range of 0.045 to 13.3 mg/dl. These studies demonstrate the successful development of an ELISA for Lp[a] protein that is insensitive to the presence of plasminogen; that heterogeneity of Lp[a] and apo[a] are an important source of variation in the assay; and the need for an appropriate Lp[a] standard in order to minimize this variation.

摘要

基于我们的研究发现,即针对人Lp[a]或载脂蛋白[a]产生的兔抗血清有可能与纤溶酶原发生交叉反应,并且在某些情况下对纤溶酶原和Lp[a]具有几乎相等的亲和力,我们开发了一种基于“夹心”ELISA的血浆Lp[a]检测方法,该方法对纤溶酶原的存在不敏感。这是通过使用抗载脂蛋白[a]作为捕获抗体,并使用抗载脂蛋白B抗体对结合的Lp[a](即载脂蛋白B-100-载脂蛋白[a]复合物)进行定量来实现的。尽管载脂蛋白[a]在大小上是异质的,但所有测试的Lp[a]颗粒,无论是纯形式还是存在于全血中,都给出了平行的剂量反应曲线,并且在免疫上是等效的。然而,当研究具有不同载脂蛋白[a]异构体的纯化Lp[a]颗粒时,基于重量,具有较大异构体的颗粒比具有较小尺寸的颗粒反应性更低。当以摩尔为基础表示蛋白质浓度时,观察到几乎相等的反应性。在84名受试者群体中,Lp[a]的分布呈偏态,三分之一的个体Lp[a]蛋白含量低于1mg/dl。所有测试的受试者Lp[a]浓度均可测,检测下限为0.030mg/dl Lp[a]蛋白。平均水平为3.2mg/dl,范围为0.045至13.3mg/dl。这些研究表明成功开发了一种对纤溶酶原存在不敏感的Lp[a]蛋白ELISA检测方法;Lp[a]和载脂蛋白[a]的异质性是该检测中变异的重要来源;以及需要合适的Lp[a]标准品以尽量减少这种变异。

相似文献

1
Enzyme-linked immunoassay for Lp[a].载脂蛋白[a]的酶联免疫测定法
J Lipid Res. 1989 May;30(5):651-62.
2
Characterization of five mouse monoclonal antibodies to apolipoprotein[a] from human Lp[a]: evidence for weak plasminogen reactivity.
J Lipid Res. 1989 Jan;30(1):23-37.
3
A selective bi-site immunoenzymatic procedure for human Lp[a] lipoprotein quantification using monoclonal antibodies against apo[a] and apoB.一种使用抗载脂蛋白[a]和载脂蛋白B单克隆抗体的人脂蛋白[a]定量选择性双位点免疫酶法。
J Lipid Res. 1989 Sep;30(9):1437-43.
4
Lipoprotein(a) and apolipoprotein(a) in a New World monkey, the common marmoset (Callithrix jacchus). Association of variable plasma lipoprotein(a) levels with a single apolipoprotein(a) isoform.新世界猴普通狨猴(绢毛猴)体内的脂蛋白(a)和载脂蛋白(a)。血浆脂蛋白(a)水平变化与单一载脂蛋白(a)异构体的关联。
Arterioscler Thromb. 1991 Jul-Aug;11(4):1030-41. doi: 10.1161/01.atv.11.4.1030.
5
Quantification of lipoprotein(a) particles containing various apolipoprotein(a) isoforms by a monoclonal anti-apo(a) capture antibody and a polyclonal anti-apolipoprotein B detection antibody sandwich enzyme immunoassay.通过单克隆抗载脂蛋白(a)捕获抗体和多克隆抗载脂蛋白B检测抗体夹心酶免疫测定法对含有各种载脂蛋白(a)异构体的脂蛋白(a)颗粒进行定量分析。
Clin Chem. 1993 Jul;39(7):1382-9.
6
Association of Lp(a) rather than integrally-bound apo(a) with triglyceride-rich lipoproteins of human subjects.人受试者中Lp(a)而非紧密结合的载脂蛋白(a)与富含甘油三酯的脂蛋白的关联。
Biochim Biophys Acta. 1997 Jun 23;1346(3):261-74. doi: 10.1016/s0005-2760(97)00049-0.
7
Lipoprotein(a) particle number assay without error from apolipoprotein(a) size isoforms.脂蛋白(a)颗粒数检测不受载脂蛋白(a)大小同型物误差的影响。
Clin Chim Acta. 2020 Jun;505:119-124. doi: 10.1016/j.cca.2020.02.030. Epub 2020 Feb 28.
8
Plasma concentrations of apolipoprotein A-I containing particles in normolipidaemic young men.正常血脂水平年轻男性中含载脂蛋白A-I颗粒的血浆浓度。
Eur J Clin Invest. 1991 Feb;21(1):118-22. doi: 10.1111/j.1365-2362.1991.tb01368.x.
9
Immunochemical characterization and quantitation of lipoprotein (a) in baboons. Development of an assay depending on two antigenically distinct proteins.
Atherosclerosis. 1988 Sep;73(1):23-31. doi: 10.1016/0021-9150(88)90159-1.
10
[Evaluation of the commercial ELISA method for lipoprotein(a) determination and interference by plasminogen].[用于脂蛋白(a)测定的商业酶联免疫吸附测定法评估及纤溶酶原的干扰作用]
Rinsho Byori. 1990 Jun;38(6):722-7.

引用本文的文献

1
Lipoprotein(a) and panvascular disease.脂蛋白(a)与泛血管疾病。
Lipids Health Dis. 2025 May 24;24(1):186. doi: 10.1186/s12944-025-02600-y.
2
The ins and outs of lipoprotein(a) assay methods.脂蛋白(a)检测方法的来龙去脉。
Arch Med Sci Atheroscler Dis. 2023 Dec 30;8:e128-e139. doi: 10.5114/amsad/176653. eCollection 2023.
3
The oxidized phospholipids linked to human apolipoprotein(a) do not derive from circulating low-density lipoproteins and are probably of cellular origin.与人类载脂蛋白(a)相关的氧化磷脂并非源自循环中的低密度脂蛋白,可能起源于细胞。
FASEB J. 2009 Mar;23(3):950-6. doi: 10.1096/fj.08-122002. Epub 2008 Nov 10.
4
Variation in ITGB3 has sex-specific associations with plasma lipoprotein(a) and whole blood serotonin levels in a population-based sample.在一个基于人群的样本中,整合素β3(ITGB3)的变异与血浆脂蛋白(a)和全血血清素水平存在性别特异性关联。
Hum Genet. 2005 Jun;117(1):81-7. doi: 10.1007/s00439-004-1250-3. Epub 2005 Apr 15.
5
Successful utilization of lyophilized lipoprotein(a) as a biological reagent.冻干脂蛋白(a)作为生物试剂的成功应用。
Lipids. 2004 Jun;39(6):589-93. doi: 10.1007/s11745-004-1268-5.
6
Issues concerning the monitoring of statin therapy in hypercholesterolemic subjects with high plasma lipoprotein(a) levels.
Lipids. 2002 May;37(5):439-44. doi: 10.1007/s11745-002-0915-1.
7
The genetic dissection of complex traits in a founder population.奠基者群体中复杂性状的基因剖析。
Am J Hum Genet. 2001 Nov;69(5):1068-79. doi: 10.1086/324025. Epub 2001 Oct 3.
8
The role of lipoprotein(a) in the pathogenesis of atherosclerotic cardiovascular disease and its utility as predictor of coronary heart disease events.
Curr Cardiol Rep. 2001 Sep;3(5):385-90. doi: 10.1007/s11886-001-0055-4.
9
Effect of sample storage on quantitation of lipoprotein(a) by an enzyme-linked immunosorbent assay.样品储存对酶联免疫吸附测定法检测脂蛋白(a)定量的影响。
Lipids. 1996 Nov;31(11):1197-203. doi: 10.1007/BF02524295.
10
Evidence that the fibrinogen binding domain of Apo(a) is outside the lysine binding site of kringle IV-10: a study involving naturally occurring lysine binding defective lipoprotein(a) phenotypes.载脂蛋白(a)的纤维蛋白原结合结构域位于kringle IV-10赖氨酸结合位点之外的证据:一项涉及天然存在的赖氨酸结合缺陷脂蛋白(a)表型的研究。
J Clin Invest. 1996 Jul 1;98(1):185-91. doi: 10.1172/JCI118765.